Thin filament-based modulation of contractile performance in human heart failure

Circulation

Volumn 110, Issue 8, 2004, Pages 982-987

  Noguchi, Teruo ^a,b   Hünlich, Mark ^a,c   Camp, Phillip C ^d   Begin, Kelly J ^a   El Zaru, Mohamed ^a   Patten, Richard ^e   Leavitt, Bruce J ^a   Ittleman, Frank P ^a   Alpert, Norman R ^a   LeWinter, Martin M ^a   VanBuren, Peter ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF KENTUCKY   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

Filaments; Heart failure; Heart assist device; Kinases; Phosphorylation

Indexed keywords

ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; PROTEIN KINASE C BETA2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPHOSPHORYLATION; ENZYME ACTIVATION; FEMALE; HEART FAILURE; HEART MUSCLE CONTRACTILE FORCE; HEART PERFORMANCE; HEART VENTRICLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE; THIN FILAMENT;

ADOLESCENT; ADULT; AGED; ANIMALS; CARDIOMYOPATHY, DILATED; CHICKENS; ENZYME ACTIVATION; FEMALE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; MICROFILAMENTS; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; SARCOMERES; TETRADECANOYLPHORBOL ACETATE;

EID: 4344595945     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000139334.43109.F9     Document Type: Article

References (27)

1. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.
2. Reiser PJ, Portman MA, Ning XH, et al. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol. 2001;280:H1814-H1820.
3. Noguchi T, Camp P, Alix SL, et al. Myosin from failing and non-failing human ventricles exhibit similar contractile properties. J Mol Cell Cardiol. 2003;35:91-97.
4. Alousi AA, Grant AM, Etzler JR, et al. Reduced cardiac myofibrillar Mg-ATPase activity without changes in myosin isozymes in patients with end-stage heart failure. Mol Cell Biochem. 1990;96:79-88.
5. Alpert NR, Gordon MS. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol. 1962;202:940-946.
6. Solaro RJ, Rarick HM. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res. 1998;83:471-480.
7. 2+-stimulated MgATPase of reconstituted actorayosin S-1. J Biol Chem. 1995;270:25445-25454.
8. Montgomery DE, Wolska BM, Pyle WG, et al. alpha-Adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI. Am J Physiol. 2002;282:H2397-H2405.
9. Sumandea MP, Pyle WG, Kobayashi T, et al. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem. 2003;278:35135-35144.
10. 2+-sensitive isoforms in the failing human heart. Circulation. 1999;99:384-391.
11. Mulieri LA, Barnes W, Leavitt BJ, et al. Alterations of myocardial dynamic stiffness implicating abnormal crossbridge function in human mitral regurgitation heart failure. Circ Res. 2002;90:66-72.
12. 2 consumption and increases contractile efficiency in rats. Am J Physiol. 2001;281:H2191-H2197.
13. Noguchi T, Kihara Y, Begin KJ, et al. Altered myocardial thin-filament function in the failing Dahl salt-sensitive rat heart: amelioration by endothelin blockade. Circulation. 2003;107:630-635.
14. VanBuren P, Alix SL, Gorga JA, et al. Cardiac troponin T isoforms demonstrate similar effects on mechanical performance in a regulated contractue system. Am J Physiol. 2002;282:H1665-H1671.
15. VanBuren P, Palmiter KA, Warshaw DM. Tropomyosin directly modulates actomyosin mechanical performance at the level of a single actin filament. Proc Natl Acad Sci USA. 1999;96:12488-12493.
16. Meyer M, Schillinger W, Pieske B, et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92:778-784.
17. Wolff MR, Buck SH, Stoker SW, et al. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J Clin Invest. 1996;98:167-176.
18. Houser SR, Margulies KB. Is depressed myocyte contractility centrally involved in heart failure? Circ Res. 2003;92:350-358.
19. 2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy. Circulation. 1992;85:518-525.
20. Holubarsch C, Ruf T, Goldstein DJ, et al. Existence of the Frank-Starling mechanism in the failing human heart: investigations on the organ, tissue, and sarcomere levels. Circulation. 1996;94:683-689.
21. Wu Y, Labeit S, LeWinter MM, et al. Titin: an endosarcomeric protein that modulates myocardial stiffness in DCM. J Card Fail. 2002;8: S276-S286. Review.
22. Takeishi Y, Chu G, Kirkpatrick DM, et al. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin invest. 1998;102:72-78.
23. Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998;97:2316-2322.
24. James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995;92:II-191-II-195.
25. Serneri GG, Modesti PA, Boddi M, et al. Cardiac growth factors in human hypertrophy: relations with myocardial contractility and wall stress. Circ Res. 1999;85:57-67.
26. Huxley AF. Muscle structure and theories of contraction. Prog Biophys Biophys Chem. 1957;7:255-317.
27. Takeishi Y, Bhagwat A, Ball NA, et al. Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. Am J Physiol. 1999;276:H53-H62.